期刊文献+

心房颤动对慢性收缩性心力衰竭患者远期预后影响分析 被引量:10

The longterm prognostic value of atrial fibrillation in patients with chronic systolic heart failure
原文传递
导出
摘要 目的探讨心房颤动(房颤)对慢性收缩性心力衰竭(chronic systoli cheart failure,CSHF)住院患者远期预后的影响。方法回顾性调查和分析湖北地区8地市12家三级甲等医院2000年至2010年CSHF住院患者资料,单因素Kaplan.Meier曲线分析房颤和非房颤组总死亡、心血管病死亡、心脏泵功能衰竭死亡(心力衰竭死亡)、心脏性猝死和栓塞相关死亡差异。多因素Cox生存分析确认心力衰竭患者不同预后的危险因素。结果①共16681例患者纳入本次研究。房颤组与非房颤组相比,年龄(64.54+13.61)岁比(62.19+15.07)岁(P〈0.01)、左心室射血分数(LVEF)37.43±12.72比38.42+13.96(P〈0.01)、心功能Ⅲ-Ⅳ级(NYHA分级)患者(5547/81.49%比7121/72.12%,P〈O.01)和病因等因素存在差异。②单因素Kaplan-Meier曲线分析发现,房颤组和非房颤组在总死亡、心血管病死亡、心力衰竭死亡和栓塞相关死亡存在差异,而在心律失常相关的心脏性猝死两组问差异无统计学意义。⑧多因素Cox回归分析发现房颤不是总死亡、心血管病死亡、心力衰竭死亡和心脏性猝死增加的独立危险因素,而增加栓塞相关死亡(HR=2.134,95%CI,1.846-2.430,P〈0.01)结论房颤不增加CSHF患者远期总死亡、心血管病死亡、心力衰竭死亡和心脏性猝死,而增加栓塞相关死亡。提示房颤引起CSHF患者远期预后不良的原因可能在于其并发症。 Objective To investigate the prognostic value of atrial fibrillation (AF) in patients with chronic systolic heart failure (CSHF). Methods Data of inhospital patients with CSHF were investigated between 2000 and 2010 from 12 hospitals in Hubei Province. Inclusion criteria: over 18 years of age, organic heart disease and with the symptom of heart failure (HF) including dyspnea and fatigue. We excluded patients with a history of myocardial infarction in the prior 12 months, congenital heart disease, pericardial disease and the history of cancer. We used X2 tests and t tests for descriptive analyses. Univariate KaplanMeier curve was performed to evaluate the difference in prognosis between AF and nonAF group. Multivariate Cox regression analysis was performed to determinate the independent risk factors of allcause mortality, cardiovascular mortality, HF mortality, sudden cardiac death (SCD) and thrombosisrelated mortality, respectively. Statistical tests were evaluated with the use of 2tailed 95% confidence levels, and tests with P〈O. 01 were considered signifi cant. Data analyses were performed with the use of SPSS 13.0 for Windows, release 15, 2006 (SPSS Inc, Chicago, llI ). Results 16681 patients were enrolled in the present study of which AF accounted for 40. 81% (6807 patients). During( 5. 82+1. 63 ) years followup, 6453 patients died. The result of univariate Kaplan Meier curve showeds there was significant difference in allcause mortality, cardiovascular mortality, HF mortality and thrombosisrelated mortality while not in SCD. The result of multivariate Cox regression analysis showedAF was not the independent risk factor of allcause mortality, cardiovascular mortality, HF mortality or SCD. AF increased thrombosisrelated mortality ( HR = 2. 134, 95% CI, 1. 846 -2. 430, P 〈 0.01 ). Conclusions AF increased thrombosisrelated mortality while not other endpoints in patients with CSHF which indicated AF correlated with adverse prognosis lies in its sideeffect while not the arrhythmia.
出处 《中华心律失常学杂志》 2012年第1期39-45,共7页 Chinese Journal of Cardiac Arrhythmias
关键词 慢性收缩性心力衰竭 心房颤动 预后 栓塞相关死亡 Chronic systolic heart failure Atrial fibrillation Prognosis Thrombosis
  • 相关文献

参考文献19

  • 1The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med, 1992, 327 :685- 691.
  • 2Swedberg K, Idanpaan HU, Remes J. for the CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). New Engl J Med, 1987, 316:1429-1435.
  • 3Middlekauff HR, Stevenson WG, Stevenson LW. Prognostic significance of atrial fibrillation in advanced heart failure: A study of 390 patients. Circulation, 1991, 84 :40-48.
  • 4Dries DL, Exner DV, Gersh BJ, et al. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A retrospective analysis of the SOLVD trials: Studies of Left Ventricular Dysfunction. J Am Coil Cardiol, 1998, 32 :695-703.
  • 5Mathew J, Hunsberger S, Fleg J, et al. Incidence, predictive factors, and prognostic significance of supraventricular tachyarrhythmias in congestive heart failure. Chest, 2000,118:914-922.
  • 6Aronow WS, Ahn C, Kronzon I. Prognosis of congestive heart failure after prior myocardial infarction in older persons with atrial fihrillation versus sinus rhythm. Am J Cardiol, 2001, 87 :224-225.
  • 7Wyse DG, Love JC, Yao Q, et al. Atrial fibrillation A risk factor for increased mortality-an AVID registry analysis. J Interv Card Electrophysiol, 2001,5:267-273.
  • 8Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: The Framingham Heart Study. Circulation, 2003, 107: 2920-2925.
  • 9Kober L, Swedherg K, McMurray JJ, et al. Previously known and newly diagnosed atrial fibrillation: A major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction. Eur J Heart Fail, 2006, 8 :591-598.
  • 10Olsson LG, Swedberg K, Ducharme A, et al. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: Results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program. J Am Coil Cardiol , 2006, 47: 1997-2004.

同被引文献99

  • 1胡大一,张鹤萍,孙艺红,姜立清.华法林与阿司匹林预防非瓣膜性心房颤动患者血栓栓塞的随机对照研究[J].中华心血管病杂志,2006,34(4):295-298. 被引量:162
  • 2戚文航.心力衰竭患者的心律失常治疗[c].中华医学会第十三次全国心血管病学术会议论文集.2011:13-14.
  • 3吴学思.欧美慢性心力衰竭2005诊疗指南特点[c].第八届中国南方国际心血管病学术会议.2006:127-129.
  • 4Abdel-Qadir HM, Tu JV, Yun L, et al. Diuretic dose and long- term outcomes in elderly patients with heart failure after hospitalization[J]. Am Heart J, 2010, 160(2): 264-271.
  • 5胡大一,马长生.心脏病学实践2007一新进展与临床案例[M].北京:人民卫生出版社,2007:459-461.
  • 6Roberge RJ, Rao P, Miske GR, et al. Diarrhea-associated over- anticoagulation in a patient taking warfarin: therapeutic role of cholestyramine[J]. Vet Hum Toxicol, 2000, 42( 6 ): 351-353.
  • 7Gandhi TK, Burstin HR, Cook EF, et al. Drug complications in outpatients[J]. J Gen Intern Med, 2000, 15(3): 149-154.
  • 8潘文志,舒先红,宿燕岗,葛均波.QRS波时限临床意义研究的进展[J].中国心脏起搏与心电生理杂志,2007,21(5):448-451. 被引量:27
  • 9Ben AhmedH, Chelli M, Selmi K, et al. Atrial fibrillation following coronary artery bypass grafting : Predictors and midterm outcome[J]. Tunis Med. 2012, 90(12):888-892.
  • 10Lee S, Monz BU, Clemens A, et al. Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom:a cross-sectional analysis using the General Practice Research Database[J]. BMJ, 2012, 2(6): 312-314.

引证文献10

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部